))
Dr. Chand Khanna | Comparative Oncology 2.0
Manage episode 440050369 series 3561919
ImpriMed, Inc.에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 ImpriMed, Inc. 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode of the Veterinary Cancer Pioneers Podcast, Dr. Rachel Venable is joined by Dr. Chand Khanna, founder and board chair of Ethos Discovery, to explore the advancements in comparative oncology. Dr. Khanna delves into the concept of Comparative Oncology 2.0, discussing the increasing collaboration between human and animal health companies. They also examine the challenges of clinical trials, regulatory hurdles, and the future potential of comparative oncology in accelerating cancer drug development. Dr. Khanna highlights key examples of successful transactions between animal health and biotech companies. The conversation reveals how veterinary oncology can significantly contribute to human cancer treatment breakthroughs. Tune in for a deep dive into cutting-edge veterinary cancer research.
- Citation mentioned in the episode: Fenger JM, Eward W, Hendricks W, McNiel E, Johannes C, et al. (2020) Delivering Innovation to Oncology Drug Development Through Cancer Drug DISCO (Development Incentive Strategy using Comparative Oncology): Perspectives, Gaps and Solutions. Ann med clin Oncol 3: 120. DOI: 10.29011/AMCO-120.000120 (https://www.gavinpublishers.com/article/view/delivering-innovation-to-oncology-drug-development-through-cancer-drug-disco-development-incentive-strategy-using-comparative-oncology-perspectives-gaps-and-solutions)
📝Transcripts are available at https://www.imprimedicine.com/podcast.
To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/personalized-prediction-profile
Music Credit: Hazy by Beat Mekanik
20 에피소드
공유
